)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Granules India
Granules India (532482) investor relations material
Granules India Q2 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 26/27 earnings summary2 Nov, 2026
Executive summary
Q2 FY27 consolidated revenue was Rs 15,599.74 million, up 20% YoY and 6% QoQ; net profit was Rs 1,818.37 million, up 39% YoY.
Eighth consecutive quarter of sequential revenue growth, supported by complex generics and broad-based demand despite higher input and logistics costs.
Financial highlights
EBITDA was Rs 3,376 million, up 21% YoY and flat QoQ; EBITDA margin was 21.6%, up 19 bps YoY and down 131 bps QoQ.
Gross margin was Rs 10,039 million, up 18% YoY; gross margin rate was 64.4%, down 134 bps YoY and 126 bps QoQ.
PAT margin was 11.7%, up 159 bps YoY and down 53 bps QoQ; PBT was Rs 2,434 million, up 38% YoY, with margin at 15.6%.
R&D expense was Rs 885 million, 5.7% of sales, up 26% YoY; manpower cost rose 18% and other expenses rose 13% YoY.
Operating cash flow was Rs 650 million, versus Rs 3,874 million in Q1 FY27 and Rs 1,937 million in Q2 FY26, reflecting planned working-capital investment.
Reported results
H1 FY27 consolidated revenue was Rs 30,367.48 million and net profit Rs 3,618.00 million; unaudited results received an unmodified limited-review conclusion.
Q2 FY27 standalone revenue was Rs 9,478.21 million and net profit Rs 1,085.16 million; H1 standalone revenue was Rs 17,496.98 million and net profit Rs 1,802.62 million.
Consolidated EPS was Rs 7.22 basic and Rs 7.03 diluted in Q2; H1 EPS was Rs 14.48 basic and Rs 14.15 diluted.
H1 FY27 consolidated operating cash flow was Rs 4,524.43 million; investing cash outflow was Rs 7,067.89 million.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Granules India
- Formulations offset Para API weakness, while higher costs and the cyber incident pressured FY24 profit.532482
Q4 23/24 - Q1 FY27 saw 22% revenue and 60% PAT growth, strong margins, and near debt-free status.532482Q1 26/27
- Record FY 2026 revenue and margin gains driven by complex generics, CDMO, and acquisitions.532482Q4 25/26
- Q2 FY 2026 revenue up 34% YoY, with margin expansion and regulatory progress supporting growth.532482Q2 25/26
- Q1 FY26 revenue up 3% YoY, but PAT fell 16% due to litigation and remediation costs.532482Q1 25/26
- Revenue and profit fell after FDA-led pause, but gross margin rose to 62% as operations resumed.532482Q2 24/25
- Q1 FY25 profit and revenue surged, driven by FD sales and North America, despite API/PFI headwinds.532482Q1 24/25
- FY25 profit and margins rose, driven by formulations and North America, despite regulatory headwinds.532482Q4 24/25
- Q3 FY25 delivered sequential growth and margin improvement despite USFDA-related disruptions.532482Q3 24/25
Next Granules India earnings date
Q3 26/2722 Jan, 2027
Granules India
Next Granules India earnings date
Q3 26/2722 Jan, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Granules India Limited is a pharmaceutical company engaged in the manufacturing and distribution of active pharmaceutical ingredients (APIs), pharmaceutical formulations intermediates (PFIs), and finished dosage forms (FDFs). The company serves global pharmaceutical markets, supplying essential medicines across therapeutic categories such as pain management, cardiovascular, and anti-infectives. The company operates manufacturing facilities in India and internationally. It is headquartered in Hyderabad, India, and its shares are listed on the BSE.